Filing Details
- Accession Number:
- 0000711377-15-000052
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-11-05 12:01:42
- Reporting Period:
- 2015-11-03
- Filing Date:
- 2015-11-05
- Accepted Time:
- 2015-11-05 12:01:42
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
711377 | Neogen Corp | NEOG | In Vitro & In Vivo Diagnostic Substances (2835) | 382367843 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1168789 | L James Herbert | Neogen Corp 620 Lesher Place Lansing MI 48912 | Chairman & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2015-11-03 | 7,500 | $54.31 | 300,605 | No | 4 | S | Indirect | See Footnote |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | See Footnote |
Footnotes
- Sales were sold under the terms of a 10b5-1 plan previously filed by the Company
- 105,500 shares are held in a limited partnership, in which Mr Herbert has a minority financial interest; the remaining shares are held in trust for Mr. Herbert's spouse